EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
"This is a big deal," says Boris Jordan, founder and executive chairman of the board of Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), referring to the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administ
